183 related articles for article (PubMed ID: 28130400)
21. Genomic Study of Chinese Quadruple-negative GISTs Using Next-generation Sequencing Technology.
Wang S; Sun RZ; Han Q; Wang SY; Wang EH; Liu Y
Appl Immunohistochem Mol Morphol; 2021 Jan; 29(1):34-41. PubMed ID: 33002893
[TBL] [Abstract][Full Text] [Related]
22. A novel fusion between CDC42BPB and ALK in a patient with quadruple wild-type gastrointestinal stromal tumor.
Huang W; Yuan W; Ren L; Xu C; Luo R; Zhou Y; Lu W; Hao Q; Xu M; Hou Y
Mol Genet Genomic Med; 2022 May; 10(5):e1881. PubMed ID: 35319816
[TBL] [Abstract][Full Text] [Related]
23. An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST).
Nannini M; Biasco G; Astolfi A; Pantaleo MA
J Med Genet; 2013 Oct; 50(10):653-61. PubMed ID: 23833252
[TBL] [Abstract][Full Text] [Related]
24. Mutational spectrum and classification of novel mutations in patients with metastatic gastrointestinal stromal tumours.
Bombac A; Zakotnik B; Bucic M; Setrajcic Dragos V; Gazic B; Stegel V; Klancar G; Novakovic S
Int J Oncol; 2020 Jun; 56(6):1468-1478. PubMed ID: 32236636
[TBL] [Abstract][Full Text] [Related]
25. MAX inactivation is an early event in GIST development that regulates p16 and cell proliferation.
Schaefer IM; Wang Y; Liang CW; Bahri N; Quattrone A; Doyle L; Mariño-Enríquez A; Lauria A; Zhu M; Debiec-Rychter M; Grunewald S; Hechtman JF; Dufresne A; Antonescu CR; Beadling C; Sicinska ET; van de Rijn M; Demetri GD; Ladanyi M; Corless CL; Heinrich MC; Raut CP; Bauer S; Fletcher JA
Nat Commun; 2017 Mar; 8():14674. PubMed ID: 28270683
[TBL] [Abstract][Full Text] [Related]
26. Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents.
Ricci R; Martini M; Ravegnini G; Cenci T; Milione M; Lanza P; Pierconti F; Santini D; Angelini S; Biondi A; Rosa F; Alfieri S; Clemente G; Persiani R; Cassano A; Pantaleo MA; Larocca LM
Clin Epigenetics; 2019 Jan; 11(1):2. PubMed ID: 30616628
[TBL] [Abstract][Full Text] [Related]
27. The genetic landscape of gastrointestinal stromal tumor lacking KIT and PDGFRA mutations.
Boikos SA; Stratakis CA
Endocrine; 2014 Nov; 47(2):401-8. PubMed ID: 25027296
[TBL] [Abstract][Full Text] [Related]
28. Molecular characterization of pediatric gastrointestinal stromal tumors.
Agaram NP; Laquaglia MP; Ustun B; Guo T; Wong GC; Socci ND; Maki RG; DeMatteo RP; Besmer P; Antonescu CR
Clin Cancer Res; 2008 May; 14(10):3204-15. PubMed ID: 18483389
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors.
Belinsky MG; Rink L; Flieder DB; Jahromi MS; Schiffman JD; Godwin AK; von Mehren M
Genes Chromosomes Cancer; 2013 Feb; 52(2):214-24. PubMed ID: 23109135
[TBL] [Abstract][Full Text] [Related]
31. KIT mutation in a naïve succinate dehydrogenase-deficient gastric GIST.
Brcic I; Kashofer K; Skone D; Liegl-Atzwanger B
Genes Chromosomes Cancer; 2019 Nov; 58(11):798-803. PubMed ID: 31124195
[TBL] [Abstract][Full Text] [Related]
32. Post-transcriptional dysregulation by miRNAs is implicated in the pathogenesis of gastrointestinal stromal tumor [GIST].
Kelly L; Bryan K; Kim SY; Janeway KA; Killian JK; Schildhaus HU; Miettinen M; Helman L; Meltzer PS; van de Rijn M; Debiec-Rychter M; O'Sullivan M;
PLoS One; 2013; 8(5):e64102. PubMed ID: 23717541
[TBL] [Abstract][Full Text] [Related]
33. Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression.
Tang CM; Lee TE; Syed SA; Burgoyne AM; Leonard SY; Gao F; Chan JC; Shi E; Chmielecki J; Morosini D; Wang K; Ross JS; Kendrick ML; Bardsley MR; Siena M; Mao J; Harismendy O; Ordog T; Sicklick JK
Oncotarget; 2016 Nov; 7(48):78226-78241. PubMed ID: 27793025
[TBL] [Abstract][Full Text] [Related]
34. Transcriptome sequencing identifies ETV6-NTRK3 as a gene fusion involved in GIST.
Brenca M; Rossi S; Polano M; Gasparotto D; Zanatta L; Racanelli D; Valori L; Lamon S; Dei Tos AP; Maestro R
J Pathol; 2016 Mar; 238(4):543-9. PubMed ID: 26606880
[TBL] [Abstract][Full Text] [Related]
35. Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis.
Andersson J; Bümming P; Meis-Kindblom JM; Sihto H; Nupponen N; Joensuu H; Odén A; Gustavsson B; Kindblom LG; Nilsson B
Gastroenterology; 2006 May; 130(6):1573-81. PubMed ID: 16697720
[TBL] [Abstract][Full Text] [Related]
36. [Clinicopathological features and prognosis of gastrointestinal stromal tumors with
Shen YY; Li XQ; Yang LX; Fang Y; Nie MM; He ZR; Hou YY; Cao H; Wang M; Shen KT
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):804-813. PubMed ID: 34530562
[No Abstract] [Full Text] [Related]
37. Molecular characterization of an Italian series of sporadic GISTs.
Origone P; Gargiulo S; Mastracci L; Ballestrero A; Battistuzzi L; Casella C; Comandini D; Cusano R; Dei Tos AP; Fiocca R; Garuti A; Ghiorzo P; Martinuzzi C; Toffolatti L; ; Bianchi Scarrà G
Gastric Cancer; 2013 Oct; 16(4):596-601. PubMed ID: 23291969
[TBL] [Abstract][Full Text] [Related]
38. Molecular Portrait of GISTs Associated With Clinicopathological Features: A Retrospective Study With Molecular Analysis by a Custom 9-Gene Targeted Next-Generation Sequencing Panel.
Qian H; Yan N; Hu X; Jiang J; Cao Z; Shen D
Front Genet; 2022; 13():864499. PubMed ID: 35547262
[No Abstract] [Full Text] [Related]
39. MiRNA profiling of gastrointestinal stromal tumors by next-generation sequencing.
Gyvyte U; Juzenas S; Salteniene V; Kupcinskas J; Poskiene L; Kucinskas L; Jarmalaite S; Stuopelyte K; Steponaitiene R; Hemmrich-Stanisak G; Hübenthal M; Link A; Franke S; Franke A; Pangonyte D; Lesauskaite V; Kupcinskas L; Skieceviciene J
Oncotarget; 2017 Jun; 8(23):37225-37238. PubMed ID: 28402935
[TBL] [Abstract][Full Text] [Related]
40. Novel oncogene and tumor suppressor mutations in KIT and PDGFRA wild type gastrointestinal stromal tumors revealed by next generation sequencing.
Hechtman JF; Zehir A; Mitchell T; Borsu L; Singer S; Tap W; Oultache A; Ladanyi M; Nafa K
Genes Chromosomes Cancer; 2015 Mar; 54(3):177-84. PubMed ID: 25427437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
